May 12, 2022
Shionogi President and CEO Isao Teshirogi Shionogi incorporated 110 billion yen for its yet-to-be-approved COVID-19 pill and vaccine into its revenue guidance for the fiscal year through March 2023. This makes up more than one-fourth of the 400-billion-yen group forecast,...read more